Crispr Therapeutics AG (CRSP)
Market Open
11 Aug, 13:47
$
53. 77
+0.27
+0.4952%
$
5.16B Market Cap
- P/E Ratio
- Div Yield
81,863 Volume
-2.71 Eps
$ 53.51
Previous Close 
Want to track CRSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crispr Therapeutics AG (CRSP) Statistics
Valuation metrics
Market Cap 5.16B
Enterprise value 5.65B
Trailing P/E (ttm) -11.24
Forward P/E -13.2
PEG ratio -2.5
Price/Sales (ttm) 385.45
Price/Book (mrq) 2.96
Enterprise Value/Revenue 422.22
Enterprise Value/EBITDA -12.45
Overview
Shares outstanding 96.39M
Float 96.02M
Shares short 22.48M
% Held by insiders 0.06%
% Held by institutions 0.72%
Average volume (10 days) 1.33M
Average volume (90 days) 1.6M
Price summary
52-Week low 44.12
52-Week high 78.48
Beta 1.74
50-Day moving average 52.48
200-Day moving average 52.25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 333,333:100,000
Last split Date 19 Jul 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -33.69%
Operating margin -39.72%
Operational effectiveness
Return on assets -0.17%
Return on equity -0.24%
Income Statement
Revenue (ttm) 4.1M
Revenue per share (ttm) 0.14
Quarterly revenue growth (yoy) 0.69%
Gross profit (ttm) -478.71M
EBITDA -531.08M
Net income to common (ttm) -568.53M
Diluted EPS (ttm) -4.67
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 2.44B
Total cash per share (mrq) 24.5
Total debt (mrq) 787.64M
Total Debt/Equity (mrq) 0.45
Current ratio (mrq) 17.85%
Book value per share (mrq) 18.1
Cash Flow
Cash flow statement -399.96M
Levered free cash flow (LFCF) -260.9M
